
In biopharma, patents are everything. In tech? Not so much.
Which is why it was unusual to see a company that’s trying to turn software into medicine announce this week that it’s bagged several patents.
In biopharma, patents are everything. In tech? Not so much.
Which is why it was unusual to see a company that’s trying to turn software into medicine announce this week that it’s bagged several patents.